Sangamo Therapeutics Announces Fourth Quarter and Full Year 2025 Earnings Call

Presentation

Gene Activation Mediated by Zinc Finger Transcriptional Regulators (ZF-TRs) as a Therapeutic Approach for CNS Disorders

Download PDF